Foothill Ranch, CA (PRWEB) January 10, 2007
The large and growing market segments in ophthalmology products are testimony to the importance of vision correction and the treatment of ophthalmic conditions, as well as the effectiveness of drugs, devices and diagnostics that have been commercialized in this arena. Double-digit growth rates reflect the increasing caseload and introduction of innovative technologies.
"The global market for ophthalmic products is clearly robust, providing numerous opportunities for competitors in local markets and worldwide," says Patrick Driscoll of MMD, LLC, publisher of the ophthalmology report. "The clinical practice of ophthalmology is strong globally, and with the aging population, development of product innovations and reimbursement support for vision products and procedures, many opportunities exist for current and hopeful competitors.
MedMarket Diligence has completed a comprehensive worldwide analysis of the market for drugs, devices and diagnostics in ophthalmology. Based on primary and secondary research among clinicians, manufacturers and other market stakeholders worldwide, the report provides extensively detailed incidence, prevalence, market size, growth, and forecasted competitor shares per country and/or region for the United States, individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; non-Japan Asia-Pacific and non-USA Americas.
This report details worldwide the incidence and prevalence by country/region of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and retinal disease), and details the current and projected market for diagnostic and therapeutic products in the management of these vision disorders, including general vision diagnostics, diagnostics for glaucoma, corneal and retinal disorders, and therapeutic options for these disorders including use of pharmaceuticals, surgery (LASIK and other refractive surgery) and devices (IOLs and other implants). The report details current products and technologies in use and the status of development of novel products under development. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast (2004-2012); competitor market shares; competitor profiles; and market opportunity.
The report contains 330 pages and 199 exhibits.
The report is described in detail, with table of contents, at http://www.mediligence.com/rpt/rpt-g125.htm.
Selected excerpts from the report are available at http://www.mediligence.com/rpt/samples/sample-rpt-g125.pdf.
Selected data has been graphed and is available at http://www.mediligence.com/rpt_smpls/G125-graphics.pdf
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets.